Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021)

Expert Opin Ther Pat. 2022 Sep;32(9):939-952. doi: 10.1080/13543776.2022.2109413. Epub 2022 Aug 9.

Abstract

Introduction: Iron oxide nanoparticles (IONPs) hold the edges of great magnetic properties and fine nanoparticle characteristics, making them an attractive therapeutic agent. In the past seven years, more in-depth investigations were devoted to the intrinsic structure, magnetic properties, and biological effects of IONPs, expanding the range of their therapeutic application scenes.

Areas covered: This review focuses on the development of IONPs for biomedical applications from the angle of the patent literature reported during the period 2015-2021.

Expert opinion: While the magnetic properties of IONPs have been extensively explored, the precise control of IONP behavior through external magnetic fields remains a challenge. Further digging into the biological effects of IONPs will facilitate the development of IONP-based immune therapies. Long-term reliable safety evaluations are of necessity and significance to promote the process of clinical translation.

Keywords: Iron oxide nanoparticles; MRI; drug delivery; theranostics; treatment.

Publication types

  • Review

MeSH terms

  • Ferric Compounds
  • Humans
  • Magnetic Iron Oxide Nanoparticles
  • Magnetite Nanoparticles* / chemistry
  • Nanoparticles* / chemistry
  • Patents as Topic

Substances

  • Ferric Compounds
  • Magnetite Nanoparticles